Maternal occupational exposure to polycyclic aromatic hydrocarbons and small for gestational age offspring

Occupational and Environmental Medicine

Volumn 71, Issue 8, 2014, Pages 529-535

  Langlois, Peter H ^a   Hoyt, Adrienne T ^a   Desrosiers, Tania A ^b   Lupo, Philip J ^c   Lawson, Christina C ^d   Waters, Martha A ^d   Rocheleau, Carissa M ^d   Shaw, Gary M ^e   Romitti, Paul A ^f   Gilboa, Suzanne M ^g   Malik, Sadia ^h  

^a TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^h UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, SMALL FOR GESTATIONAL AGE; LOGISTIC MODELS; MATERNAL EXPOSURE; MOTHERS; OCCUPATIONAL EXPOSURE; ODDS RATIO; POLYCYCLIC HYDROCARBONS, AROMATIC; PREGNANCY; PREGNANCY OUTCOME; YOUNG ADULT;

EID: 84905089880     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oemed-2013-101833     Document Type: Article

References (40)

1. ATSDR (Agency for Toxic Substances and Disease Registry). Toxicological Profile for Polycyclic Aromatic Hydrocarbons (PAHs) (Update). (Monograph) US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, 1995.
2. Brandt HC, Watson WP. Monitoring human occupational and environmental exposures to polycyclic aromatic compounds. Ann Occup Hyg 2003;47:349-78. (Pubitemid 36903225)
3. Hansen AM, Mathiesen L, Pedersen M, et al. Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies - a review. Int J Hyg Environ Health 2008;211:471-503.
4. Sjaastad AK, Svendsen K. Exposure to polycyclic aromatic hydrocarbons (PAHs), mutagenic aldehydes, and particulate matter in Norwegian a la carte restaurants. Ann Occup Hyg 2009;53:723-9.
5. Madhavan ND, Naidu KA. Polycyclic aromatic hydrocarbons in placenta, maternal blood, umbilical cord blood and milk of Indian women. Hum Exp Toxicol 1995;14:503-6.
6. Arnoud JP, Verhoest P, Bach V, et al. Detection of benzo[a]pyrene-DNA adducts in human placenta and umbilical cord blood. Hum Exp Toxicol 1997;16:716-21. (Pubitemid 28008935)
7. Gladen BC, Zadorozhnaja TD, Chislovska N, et al. Polycyclic aromatic hydrocarbons in placenta. Hum Exp Toxicol 2000;19:597-603. (Pubitemid 32124419)
8. Ravindra K, Mittal AK, Van Grieken R. Health risk assessment of urban suspended particulate matter with special reference to polycyclic aromatic hydrocarbons: a review. Rev Environ Health 2001;16:169-89. (Pubitemid 33081433)
9. Myers SR, Zamora R, Ali Y, et al. Analysis of polycyclic aromatic hydrocarbons in amniotic fluid samples from smokers and nonsmokers. Polycycl Aromat Compd 2008;28:39-66.
10. Castano-Vinyals G, D'Errico A, Malats N, et al. Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution. Occup Environ Med 2004;61:e12.
11. Choi H, Rauh V, Garfinkel R, et al. Prenatal exposure to airborne polycyclic aromatic hydrocarbons and risk of intrauterine growth restriction. Environ Health Perspect 2008;116:658-65. (Pubitemid 351864283)
12. Bruckner JV. Differences in sensitivity of children and adults to chemical toxicity: the NAS panel report. Regul Toxicol Pharmacol 2000;31:280-5. (Pubitemid 30640372)
13. Rennie MY, Detmar J, Whiteley KJ, et al. Vessel tortuosity and reduced vascularization in the fetoplacental aterial tree after maternal exposure to polycyclic aromatic hydrocarbons. Am J Physiol Heart Circ Physiol 2011;300:H675-84.
14. Detmar J, Rennie MY, Whitely KJ, et al. Fetal growth restriction triggered by polycyclic aromatic hydrocarbons is associated with altered placental vasculature and AhR-dependent changes in cell death. Am J Physiol Endocrinol Metab 2008;295:E519-530.
15. Snijder CA, Roeleveld N, te Velde E, et al. Occupational exposure to chemicals and fetal growth: the Generation R study. Hum Reprod 2012;27:910-20.
16. Dejmek J, Solansky I, Benes I, et al. The impact of polycyclic aromatic hydrocarbons and fi ne particles on pregnancy outcome. Environ Health Perspect 2000;108:1159-64. (Pubitemid 32049101)
17. Perera FP, Rauh V, Tsai WY, et al. Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population. Environ Health Perspect 2003;111:201-5. (Pubitemid 36305318)
18. Choi H, Jedrychowski W, Spengler J, et al. International studies of prenatal exposure to polycyclic aromatic hydrocarbons and fetal growth. Environ Health Perspect 2006;114:1744-50. (Pubitemid 44718282)
19. Perera FP, Whyatt RM, Jedrychowski W, et al. A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol 1998;147:209-314.
20. Tang D, Li TY, Liu JJ, et al. PAH-DNA adducts in cord blood and fetal and child development in a Chinese cohort. Environ Health Perspect 2006;114:1297-300. (Pubitemid 44184694)
21. Sram RJ, Binkova B, Dejmek J, et al. Association of DNA adducts and genotypes with birth weight. Mutat Res 2006;608:121-8. (Pubitemid 44322062)
22. Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public Health Reports 2001;116(Suppl 1):32-40. (Pubitemid 32822091)
23. Zhang J, Bowes WA. W. Birth weight-for-gestational-age patterns by race, sex, and parity in the United States population. Obstet Gynecol 1995;86:200-8.
24. Overpeck MD, Hediger ML, Zhang J, et al. Birth weight for gestational age of Mexican American infants born in the United States. Obstet Gynecol 1999;93:943-7. (Pubitemid 29247100)
25. United States Department of Labor, Bureau of Labor Statistics. Standard Occupational Classification. http://www.bls.gov/soc/soc-majo.htm (accessed 29 Aug 2009).
26. United States Department of Labor, Bureau of Labor Statistics. North American Industry Classification System. http://www.bls.gov/bls/naics.htm (accessed 29 Aug 2009).
27. Jackson LW, Correa-Villasenor A, Lees PS, et al. Parental lead exposure and total anomalous pulmonary venous return. Birth Defects Res A Clin Mol Teratol 2004;70:185-93. (Pubitemid 38581384)
28. Correa A, Min YI, Stewart PA, et al. Inter-rater agreement of assessed prenatal maternal occupational exposures to lead. Birth Def Res A Clin Mol Teratol 2006;76:811-24.
29. Verburg BO, Steegers EA, De Ridder M, et al. New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol 2008;31:388-96.
30. Topinka J, Milcova A, Libalova H, et al. Biomarkers of exposure to tobacco smoke and environmental pollutants in mothers and their transplacental transfer to the foetus. Part I: bulky DNA adducts. Mutat Res 2009;669:13-9.
31. Perera FP, Dickey C, Santella R, et al. Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis 1994;15:2905-10.
32. Olsson AC, Fevotte J, Fletcher T, et al. Occupational exposure to polycyclic aromatic hydrocarbons and lung cancer risk: a multicenter study in Europe. Occup Environ Med 2010;67:98-103.
33. Cogswell ME, Bitsko RH, Anderka M, et al. Control selection and participation in an ongoing, population-based, case-control study of birth defects. Am J Epidemiol 2009;170:975-85.
34. Alexander GR, Himes JH, Kaufman RB, et al. A United States national reference for fetal growth. Obstet Gynecol 1996;87:163-8. (Pubitemid 26033124)
35. Zhang J, Merialdi M, Platt LD, et al. Defining normal and abnormal fetal growth: promises and challenges. Am J Obstet Gynecol 2010;202:522-8.
36. Usher R, McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks gestation. J Pediatr 1969;74:901-10.
37. Breart G, Rabarison Y, Plouin PF, et al. Risk of fetal growth retardation as a result of maternal hypertension: preparation to a trial on antihypertensive drugs. Dev Pharmacol Ther 1982;(4 Suppl):116-23. (Pubitemid 12027935)
38. Seeds JW, Peng T. Impaired growth and risk of fetal death: is the tenth percentile the appropriate standard? Am J Obstet Gynecol 1998;178:658-69. (Pubitemid 28196871)
39. Zhang J, Mikolajczyk R, Grewal J, et al. Prenatal application of the individualized fetal growth reference. Am J Epidemiol 2011;173:539-43.
40. McIntire D, Bloom S, Casey B, et al. Birth weight in relation to morbidity and mortality among newborn infants. New Eng J Med 1999;340:1234-8. (Pubitemid 29181643)